Coherus Oncology (CHRS) Change in Inventory (2018 - 2026)

Coherus Oncology has disclosed Change in Inventory across 9 years of filings, most recently posting -$437000.0 for Q2 2026.

• In Q2 2026, Change in Inventory rose 88.41% year-over-year to -$437000.0; the TTM figure through Jun 2026 stood at $9.5 million (down 70.16% YoY), while the FY2025 annual figure was $17.1 million, down 46.46% from the prior year.
• Change in Inventory came in at -$437000.0 for Q2 2026 at Coherus Oncology, down from $11.3 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $23.4 million in Q3 2022 to a low of -$3.8 million in Q2 2025.
• Average Change in Inventory over 5 years is $8.6 million, with a median of $8.4 million recorded in 2022.
• Year-over-year, Change in Inventory jumped 443.63% in 2022 and slumped 153.08% in 2025.
• Over 5 years, Change in Inventory stood at $9.8 million in 2022, then grew by 20.44% to $11.8 million in 2023, then slumped by 45.28% to $6.5 million in 2024, then sank by 82.74% to $1.1 million in 2025, then slumped by 139.23% to -$437000.0 in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were -$437000.0 in Q2 2026, $11.3 million in Q1 2026, and $1.1 million in Q4 2025.